Background The mutation frequencies of three common deafness genes (MT-RNR1 m.1555A>G, GJB2, and SLC26A4) among patients with nonsyndromic sensorineural hearing loss (NSHL) were different in previous studies. Inconsistent selection criteria for recruiting patients could have led to differences in estimating the frequencies of genetic mutations thus resulting in different mutation frequencies among these studies. The aim of this study was to reveal the differences in the mutation spectrums of the three common genes between familial and sporadic Chinese Han patients. Methods Totally, 301 familial probands and 703 sporadic patients with NSHL were enrolled in this study. Three genes, MT-RNR1 m.1555A>G, GJB2, and SLC26A4, were screened for mutation in our study cohort. A χ 2 test was performed to compare the mutation frequencies between the two groups.
H earing loss is one of the most common types of sensory impairment. According to the Chinese Second Sample Survey of Persons with Disabilities in 2006, patients with hearing loss and speech disabilities accounted for up to 21.31 million. The most important factors leading to hearing loss are genetic and environmental factors, with genetic factors being attributed to over 50% of cases. 1 There are at least 46 known genes related to nonsyndromic sensorineural hearing loss (NHSL), of which the most common nuclear chromosome genes are GJB2 and SLC26A4, and the most common mitochondrial DNA mutation is the mitochondrial MT-RNR1 m.1555A>G mutation. 2 Many studies have been conducted on the mutation spectrums of the three deafness genes in different regions and races. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] In general, the population with the same genetic background should have similar genetic mutation spectrums. In Caucasians of Europe, Americas, and India, the mutation hot spot of GJB2 gene was c.35delG, 3, 4 but in Mongoloids of China, Japan, and South Korea, the hot spot was c.235delC. [5] [6] [7] In British Bangladeshi population and the Spanish Romani, the mutation hot spot was c.71G>A (p.Trp24X). 8, 9 As for SLC26A4 gene, the mutation hot spot was c.919-2A>G in China, 10 c.2168A>G (p.His723Arg) in Japan and South Korea, 7,11 c.1259C>T (p.Thr420Ile) in Iran, 12 c.716T>A (p.Val239Asp) in Pakistan, 13 and c.1246A>C (Thr416Pro) and c.1001+1 G>A in Northern Europe. 14 This information shows that deafness gene mutation spectrums have racial and geographical characteristics.
However, in-depth analysis of this information revealed large differences and some inconsistencies in data from many studies. Disease-causing mutation frequency (homozygous or compound heterozygous mutation) and mutation carrying frequency (homozygous, compound heterozygous, and heterozygous mutation) in the same or similar region and race patients were different in many different studies. For example, MT-RNR1 m.1555A>G mutation frequencies in Chinese patients with NSHL were reported from 1.67% to 15.5%. 5, [15] [16] [17] [18] In Caucasians of Europe, America, and Africa, the mutation frequencies were from 0 to 2.4%. [19] [20] [21] [22] [23] As for GJB2, the differences between reported mutation frequencies were more obvious. Reported carrying frequencies of GJB2 mutations were from 14.8% to 41% in China 5,24-26 and 14.7% to 50.0% in Europe, 19, [27] [28] [29] [30] while disease-causing mutation frequencies were from 3.01% to 26.3% in North America. [31] [32] [33] Differences in reported mutation frequencies of SLC26A4 gene also existed. These differences have not been explained by the regional or ethnic differences, so there must be one or more factors influencing these mutation frequencies.
Kimberling 34 first raised the following question: Why did so large difference among mutation frequencies in the same region or ethnic origin exist? Kimberling found that inconsistent selection criteria for recruiting patients could lead to substantial differences in estimating the frequencies of genetic mutations, thus resulting in different mutation frequencies among studies (selection bias). According to his viewpoint, the mutation frequencies between patients of different sources or characteristics may be different. In this study, we screened the mutations of MT-RNR1 m.1555A>G, GJB2, and SLC26A4 and compared the difference in mutation frequencies between familial probands group and sporadic patients group in Chinese Han.
METHODS
The study was approved by the Ethics Committee of the Chinese People's Liberation Army General Hospital, as it met all ethics requirement. All investigation had been conducted according to the principles expressed in the Declaration of Helsinki. All patients provided their written informed consent to participate in the study.
Patients and mesurements
From 2003 to 2009, 301 deaf families (families with two or more deaf patients) and 703 sporadic patients were recruited from special education schools (SES) in eight provinces in China and the outpatient department in the Clinical Hearing Diagnostic Center, Department of Otolaryngology, Head and Neck Surgery, People's Liberation Army General Hospital (Beijing, China). Peripheral venous blood samples were collected. Patients, patient guardians, or teachers completed a questionnaire which collected the history, including hearing loss history, family history, and risk factors. A professional technician checked the audiological level of patients by pure tone audiometry and acoustic impedance. The audiological data were evaluated based on the Grades of Hearing Impairment recommended by the World Health Organization in 1997 in Geneva (http://www.who.int/pbd/ deafness/hearing_ impairment_grades/en/index.html). Informed consent, blood sample, and clinical evaluations were collected from all the participants according to the protocols approved by the Institution Review Board of the Ethics Committee of the Chinese People's Liberation Army General Hospital.
Genomic DNA was extracted from peripheral venous blood using phenol extraction. MT-RNR1, the second exon of GJB2, and exons 8, 10, 17, and 19 of SLC26A4 including the flanking sequences were amplified by polymerase chain reaction (PCR) using the genomic DNA as template. The primer pairs were designed referring to Guo et al's 5 and Wang et al's 10 previous reports and synthesized by Invitrogen Corporation. All PCR reactions were conducted in an ABI 9700 PCR Thermal Cycler. The PCR products were separated by 1.5% agarose gel electrophoresis and showed a single and specific band with correct size.
MT-RNR1 sequence contains a single restriction site between 1 552 and 1 556 bp which can be specifically recognized by Alw26I (BsmAI) endonuclease. PCR was performed as previously described followed by Alw26I digestion. If MT-RNR1 m.1555A>G point mutation does not exist, the PCR product can be cut by Alw26I and results in two bands of 326 bp and 441 bp. Otherwise, the PCR product shows a 767 bp band if it carries the point mutation.
The PCR products of GJB2 and SLC26A4 were directly sequenced, and the PCR products of MT-RNR1 m.1555A>G with single band were also sequenced to further confirm MT-RNR1 m.1555A>G mutation. All PCR products were purified with Millipore plate and then sequenced using an ABI 3730 Sequencer (Applied Biosystems ). Sequencing data were analyzed and aligned with NCBI GenBank reference sequences of MT-RNR1 (AC_000021), GJB2 (NC_000013), and SLC26A4 (NC_000007.13) using Sequencher 4.8 Demo software.
Statistical analysis
Comparisons of mutation frequencies of MT-RNR1 m.1555A>G, GJB2, or SLC26A4 between familial probands group and sporadic patients group were conducted by χ 2 test and t test using SPSS18.0 software (SPSS Inc., USA). A P <0.05 was considered as statistically significant.
RESULTS

Demographic characteristics of the subjects
The 301 familial probands and 703 sporadic patients with NSHL were all Chinese Han. Most of them had severe or profound hearing loss, which accounted for 98.01% (295/301) in familial probands and 98.86% (695/703) in sporadic patients. The demographic characteristics of probands and sporadic patients are summarized in Table 1 . In general, the familial probands were older than sporadic patients (t test, P <0.05), while the proportion of male to female in sporadic patients was higher than in familial probands (χ 2 test, P <0.05).
Result of mutation screening in familial probands
Of 301 familial probands, 37 were found to have the MT-RNR1 m.1555A>G mutation. The mutation frequency was 12.29% (37/301).
Forty-four probands were found carrying GJB2 diseasecausing mutation (homozygous or compound heterozygous mutation). Seventeen probands were found to have monoallelic mutation (heterozygous mutation). So in familial probands, the disease-causing mutation frequency of GJB2 was 14.62% (44/301), and mutation carrying frequency was 20.27% (61/301). Table 2 shows the mutational site and the number and frequencies of mutated alleles. c.235delC and c.299_300delAT were the common variant alleles of GJB2 in these probands. We also found two novel variants (c.250G>A and c.187G>T).
Fifty-five probands were found to carry SLC26A4 diseasecausing mutation and 35 probands had monoallelic mutation. The disease-causing mutation frequency and mutation carrying frequency of SLC26A4 were 18.27% (55/301) and 29.90% (90/301), respectively. As shown in Table 2 , the most common variant allele was c.919-2A>G. The novel variants of c.1238A>G, c.1990G>A, c.1982A>G, and c.1970G>T were found.
In Chinese Han familial probands, 45.18% (136/301) patients had disease-causing mutation of GJB2 (12.29%, 44/301) or SLC26A4 (18.27%, 55/301) and MT-RNR1 m.1555A>G (12.29%, 37/301) mutation.
Result of mutation screening in sporadic patients
A total of 25 sporadic patients were detected to carry the MT-RNR1 m.1555A>G mutation among the 703 patients. The frequency of MT-RNR1 m.1555A>G mutation was 3.56% (25/703) in these sporadic patients with NSHL.
Of 703 sporadic patients, 131 were found to carry GJB2 disease-causing mutation, and 39 were found to have monoallelic mutation. In these sporadic patients, the disease-causing mutation frequency of SLC26A4 was 18.63% (131/703), and mutation carrying frequency was 24.18 (170/703). Variant alleles of GJB2 in the sporadic patients are detailed in Table 3 . c.235delC and c.299_300delAT were also common variant alleles of GJB2 in sporadic patients. Five novel variants were found (c.478G>A, c.407A>G, c.257C>G, c.9G>A, and c.499G>A).
A total of 133 sporadic patients were detected to carry SLC26A4 disease-causing mutation, and 75 had monoallelic mutation. The disease-causing mutation frequency and mutation carrying frequency of SLC26A4 were 18.92% (133/703) and 29.59% (208/703), respectively. c.919-2A>G is the most common variant allele, and four novel variants 
Statistical results
As shown in Table 4 , a χ 2 test showed that the mutation frequency of MT-RNR1 m.1555A>G in familial probands was significantly higher than in sporadic patients (χ 2 test, P=0.000), while there were no significant differences in GJB2 or SLC26A4 mutation frequencies including diseasecausing frequency and mutation carrying frequency between the familial and sporadic groups (χ 2 test, P >0.05).
DISCUSSION
In both Chinese Han familial probands and sporadic patients, the proportions of patients with NSHL led by mutations of the three genes of MT-RNR1 m.1555A>G, GJB2, and SLC26A4 were very high (45.18% and 41.11%). The three genes were the most important etiological factors in Chinese Han patients with NSHL. SLC26A4 and GJB2 were more frequent than MT-RNR1 m.1555A>G. Hilgert et al 2 believed that the most frequent mutation was GJB2, followed by SLC26A4, MYO15A, OTOF, CDH23, and TMC1 of the 46 known nonsyndromic deafness genes. But, as shown in Table 4 , we found SLC26A4 gene mutation frequency (disease-causing mutation frequency or mutation carrying frequency) was not lower than the frequency of GJB2 in both Chinese Han familial probands and sporadic patients. Furthermore, because we screened only four exons of SLC26A4 and some mutation in other exons could not be found in this study, the actual mutation frequency of SLC26A4 might be higher. So, SLC26A4 was also the most frequent mutation in Han Chinese. The hot spots of GJB2 and SLC26A4 were c.235delC and c.919-2A>G in Chinese Han, which were consistent with the previous reports.
In Chinese Han, the mutation frequencies of MT-RNR1 m.1555A>G in hearing impairment familial probands (12.29%) were significantly higher than in sporadic patients (3.56%). This showed that MT-RNR1 m.1555A>G was more frequent in familial patients than in sporadic patients in Chinese Han. Therefore, when the proportional relations between familial patients and sporadic patients in different studies were not consistent, the results of epidemiological data of MT-RNR1 m.1555A>G might be different. No significant differences in GJB2 or SLC26A4 mutation frequencies including disease-causing frequency and mutation carrying frequency between the familial and sporadic groups indicated that the mutation of GJB2 or SLC26A4 in Chinese Han was very common not only in familial probands, but also in sporadic patients.
In this study, we found the difference in MT-RNR1 m.1555A>G mutation frequencies between familial probands and sporadic patients in Chinese Han by comparative study, which is a further evidence that the mutation frequencies among patients of different sources or characteristics might be different. Besides the pair of familial and sporadic factors, we believe that there might be more factors affecting the results of gene mutation frequency, such as the pairs of aminoglycoside antibioticsinduced deafness (AAID) and non-AAID, prelingual and postlingual, and SES and outpatient departments. It is very essential to research the differences in gene mutation frequencies between these factors by comparative studies in order to avoid selection bias in future studies. 
